These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34132679)

  • 21. Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT.
    Kunz WG; Eschbach RS; Stahl R; Kazmierczak PM; Bartenstein P; Rominger A; Auernhammer CJ; Spitzweg C; Ricke J; Cyran CC
    Cancer Imaging; 2018 Sep; 18(1):34. PubMed ID: 30236163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatostatin receptor imaging with [
    Zhao L; Pang Y; Wang Y; Chen J; Zhuang Y; Zhang J; Zhao L; Sun L; Wu H; Chen X; Lin Q; Chen H
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1360-1373. PubMed ID: 34665275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discordant Uptake Between Diagnostic 68Ga-HA-DOTATATE PET/CT and Posttherapy 177Lu-HA-DOTATATE SPECT/CT in Patients With Neuroendocrine Tumors.
    Huizing DMV; Aalbersberg EA; van der Hiel B; Stokkel MPM; Versleijen MWJ
    Clin Nucl Med; 2021 Sep; 46(9):e475-e477. PubMed ID: 33782314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sacral Insufficiency Fracture on 68Ga-DOTATATE PET/CT.
    Filizoglu N; Bugdayci O; Ozguven S
    Clin Nucl Med; 2021 Oct; 46(10):e490-e491. PubMed ID: 33661205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrent Glomus Jugulare Tumor Invading the Cerebellum on 68Ga-DOTATATE PET/CT.
    Balaban Genc ZC; Filizoglu N; Ozguven S
    Clin Nucl Med; 2022 May; 47(5):e406-e407. PubMed ID: 35261358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Combined Interpretation of 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT in Metastatic Gastroenteropancreatic Neuroendocrine Tumors: A Classification System With Prognostic Impact.
    Hayes AR; Furtado O'Mahony L; Quigley AM; Gnanasegaran G; Caplin ME; Navalkissoor S; Toumpanakis C
    Clin Nucl Med; 2022 Jan; 47(1):26-35. PubMed ID: 34874347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 68Ga-DOTATATE PET/CT Distinguishes Neuroendocrine Tumor Mesenteric Lymph Node Metastasis From an Extensive IgG4-Positive Fibrosis Surrounding It.
    Ahmadi Bidakhvidi N; Cuyle PJ; Sagaert X; Ballaux F; Deroose CM
    Clin Nucl Med; 2021 Oct; 46(10):e510-e512. PubMed ID: 34034320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discordance Between Histopathologic Grading and Dual-Tracer PET/CT Findings in Metastatic NETs and Outcome of
    Adnan A; Basu S
    J Nucl Med Technol; 2022 Sep; 50(3):248-255. PubMed ID: 34876476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unexpected Detection of Skeletal Muscle Renal Cell Carcinoma Metastasis With 99m Tc-EDDA/HYNIC-Tyr3-Octreotide (Tektrotyd) Scan.
    Fuoco V; Barisella M; Lorenzoni A; Verzoni E; Maccauro M
    Clin Nucl Med; 2022 Dec; 47(12):e762-e764. PubMed ID: 35619201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 68Ga-DOTATATE and 68Ga-PSMA Uptake in Granulomatous Prostatitis.
    Ruan D; Sun L
    Clin Nucl Med; 2022 Apr; 47(4):359-361. PubMed ID: 35020658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The diagnostic role of 68Ga-DOTATATE PET/CT in the detection of neuroendocrine tumours.
    Łapińska G; Bryszewska M; Fijołek-Warszewska A; Kozłowicz-Gudzińska I; Ochman P; Sackiewicz-Słaby A
    Nucl Med Rev Cent East Eur; 2011; 14(1):16-20. PubMed ID: 21751167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Superiority of 68Ga-FAPI-04 in Delineation of Soft Tissue and Liver Metastases in Chromophobe Renal Cell Carcinoma for Restaging.
    Xie F; Fu L; Zhou W
    Clin Nucl Med; 2022 Dec; 47(12):e758-e759. PubMed ID: 36342807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of 68Ga-Dotatate PET/CT and 18F-FDOPA PET/CT for the diagnosis of pancreatic neuroendocrine tumors in a MEN1 patient.
    Jullien M; Reichert T; D'Anella P; Castinetti F; Barlier A; Brue T; Taieb D; Cuny T
    Ann Endocrinol (Paris); 2020 Feb; 81(1):39-43. PubMed ID: 31982106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Head-to-Head Comparison of
    Zhu W; Cheng Y; Wang X; Yao S; Bai C; Zhao H; Jia R; Xu J; Huo L
    J Nucl Med; 2020 Jun; 61(6):897-903. PubMed ID: 31676731
    [No Abstract]   [Full Text] [Related]  

  • 35. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
    Sampathirao N; Basu S
    J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Detection of neuroendocrine tumors by positron emission tomography-computed tomography with 68Ga-DOTATATE: report of one case].
    Amaral H; Pruzzo R; Redondo F; Gil MC; Pizarro A; de la Fuente H; Butte JM; Coudeu TM
    Rev Med Chil; 2009 Apr; 137(4):537-41. PubMed ID: 19623420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Case of Brown Tumor on 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT.
    Yao X; Ou X
    Clin Nucl Med; 2022 Jan; 47(1):88-89. PubMed ID: 34874352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of 68Ga-DOTATATE uptake on PET/CT with pathologic features of cellular proliferation in neuroendocrine neoplasms.
    Karls S; Gold R; Kravets S; Wang Y; Cheng S; Perez K; Chan J; Jacene H
    Ann Nucl Med; 2021 Sep; 35(9):1066-1077. PubMed ID: 34146243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A frequency and semiquantitative analysis of pathological 68Ga DOTATATE PET/CT uptake by primary site-dependent neuroendocrine tumor metastasis.
    Kunikowska J; Pawlak D; Kolasa A; Mikołajczak R; Królicki L
    Clin Nucl Med; 2014 Oct; 39(10):855-61. PubMed ID: 25072928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors.
    Kayani I; Conry BG; Groves AM; Win T; Dickson J; Caplin M; Bomanji JB
    J Nucl Med; 2009 Dec; 50(12):1927-32. PubMed ID: 19910422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.